Navigation Links
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
Date:6/7/2009

rmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 27,900 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
2. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
10. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
11. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Mich., Jan. 23, 2012 Perrigo Company (Nasdaq: PRGO;TASE) announced ... Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine ... the owner of the New Drug Application (NDA) of its ... Impax Laboratories, Inc. (Nasdaq: IPXL ), who will ...
... (OTC: PLCSF), a company focused on innovative medical device ... in the CIN-RG trial, the company,s pivotal trial to ... System™ in the prevention of Contrast-Induced Nephropathy (CIN).  This ... regulatory approval by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 2Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 3First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
(Date:5/20/2013)... (PRWEB) May 20, 2013 A novel service ... Clinic . The company has been in the field of ... initiative will make sure that scholars are able to maintain ... service has three stages and has been priced at $1000. ... a dedicated mentor assigned to the project, who will handle ...
(Date:5/20/2013)... Inspired by her client’s total weight loss ... , Shanna Layne came up with the charity idea “Our ... business host a clothing drive to support a local ... worth of clothing to Something Special, the local Montgomery County ... was a huge success. , Being a huge advocate and ...
(Date:5/20/2013)... The report, "Gluten-Free Products Market ... Baking Mixes & Flour, Meat & Poultry Products), ... Global Trends & Forecasts To 2018" defines and ... and forecasting of the global revenue and volume ... and restraining factors for the global gluten-free product ...
(Date:5/20/2013)... Nordic Naturals®, the leading manufacturer of omega-3 ... powerful EPA-only concentrates available without a prescription. With 1600 ... serving, EPA Elite provides high intensity, therapeutic support for ... anti-inflammatory pathways. , EPA Elite is an EPA-only ... to a much-studied ethyl-ester EPA formulation. This dose of ...
(Date:5/20/2013)... My Fit Foods continues its ... location bringing the healthy grab and go concept to the ... Foods store, located at 7979 N. Macarthur Blvd. Suite 110, ... snacks for the taking. , My Fit Foods was founded ... Mendias, a former Marine and Houston personal trainer who was ...
Breaking Medicine News(10 mins):Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center 2Health News:Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center 3Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 2Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 3Health News:Nordic Naturals Launches Innovative EPA Elite™ 2Health News:My Fit Foods Opens a New Retail Location in Las Colinas Thursday, May 23rd 2
... targeted therapy against the BRAF/MAPK pathway with immunotherapy shows ... of melanoma, according to results of a preclinical study ... the American Association for Cancer Research. "Our results ... therapy and immunotherapy in the treatment of this most ...
... Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation ... mitral position. This minimally invasive procedure was used ... at high surgical risk. Full details of the ... Catheterization and Cardiovascular Interventions , a journal published by ...
... more likely to underestimate their preschool children,s weight when ... or gaining weight too fast, a study by the ... The study, published online earlier this ... not hesitate to wield their influence in helping parents ...
... ... holistically reverse symptoms associated with Polycystic Ovarian Syndrome and Insulin Resistance in her e-book. ... (PRWEB) ... are now able to lose weight and achieve hormonal balance without taking any prescription ...
... male-only protein found in rats helps control stress signals in ... -- When it comes to stress, women are twice as ... and/or post-traumatic stress, and now a new study in rats ... evidence in animals that suggests that males benefit from having ...
... Journal of Thoracic Oncology features a study aimed ... nab-paclitaxel with carboplatin as a first-line therapy in patients ... researchers with a data needed to guide a phase ... for patients with NSCLC is carboplatin plus solvent-based paclitaxel. ...
Cached Medicine News:Health News:Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment 2Health News:Elderly patients in need of heart valve replacements have alternative to surgery 2Health News:Pediatricians can help parents recognize overweight preschoolers 2Health News:Pediatricians can help parents recognize overweight preschoolers 3Health News:Women with Polycystic Ovarian Syndrome and Insulin Resistance can Lose Weight and Balance Hormones Naturally with Katie Humphrey's New E-book 2Health News:Females May Be Naturally More Prone to Stress: Animal Study 2Health News:Novel paclitaxel formulation encouraging for treating advanced lung cancer 2
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
... in interbody fusion are to ... restore disc space height and ... an enviroment for bone fusion ... Allograft is designed to promote ...
... highly adaptable and therefore suitable for a ... its extraordinary small outer diameter and the ... a simple but secure and reliable fixation ... instruments around the corner. These characteristics make ...
A new flexible endoscope with an ultra dense optic fiber system. Its two working and irrigation channels and steering mechanism makes it ideal for a multipurpose use in neurosurgical endoscopy i.e. V...
Medicine Products: